Collectively, these findings establish ENO1 as a crucial mediator of UCHL3’s oncogenic effects through AKT/CCND1 signaling activation in GC progression, with their coordinated expression patterns carrying clinical prognostic significance. This evidence concerns the gene UCHL3 and gastric cancer.